Public annual accounts

Dr. Sophie De Cauwer financials

Name: Dr. Sophie De Cauwer financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Sophie De Cauwer, with comparable measures and links to available source documents.

Company overview

Registry number

0897391540

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for Dr. Sophie De Cauwer

2025 versus 2024

Operating line: €223,541
EBITDA: €219,744
Total assets: €1,171,898
Equity: €968,757

EBITDA margin +98.3% · Equity ratio +82.7%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€223,541	€219,744	€1,171,898	€968,757	-
202430 Sept 2024	€295,830	€292,034	€1,226,938	€833,792	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202530 Sept 2025

€223,541

€219,744

€1,171,898

€968,757

202430 Sept 2024

€295,830

€292,034

€1,226,938

€833,792